CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Earnings & Estimates
USA - NASDAQ:CCRN - US2274831047 - Common Stock
13.435 USD
+0.07 (+0.49%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.807B 67.39% | 2.02B -28.04% | 1.344B -33.46% | 1.139B -15.25% | 1.138B -0.09% | 1.149B 0.97% | |
| EBITDA YoY % growth | 293.9M 89.61% | 135.516M -53.89% | 19.443M -85.65% | 37.048M 90.55% | 46.426M 25.31% | 58.303M 25.58% | |
| EBIT YoY % growth | 281.3M 93.87% | 117.169M -58.35% | 1.243M -98.94% | -1.745M -240.36% | 12.025M 789.23% | 12.24M 1.79% | |
| Operating Margin | 10.02% | 5.80% | 0.09% | -0.15% | 1.06% | 1.07% | |
| EPS YoY % growth | 5.26 71.90% | 2.21 -57.98% | 0.45 -79.64% | 0.14 -68.27% | 0.28 96.43% | 0.27 -5.45% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.04 -68.83% | 0.05 31.76% | 0.02 -60.34% | 0.05 610.00% | 0.06 63.62% | 0.09 74.18% | 0.03 28.59% | 0.06 20.00% | 0.08 33.33% | 0.09 |
| Revenue Q2Q % growth | 276.17M -12.36% | 283.64M -8.49% | 277.21M -5.52% | 274.84M 0.28% | 278.12M 0.71% | 290.04M 2.26% | 284.17M 2.51% | 280.44M 2.04% | 286.02M 2.84% | 297.97M 2.73% |
| EBITDA Q2Q % growth | 7.623M -56.96% | 8.71M -57.53% | 6.965M 13.49% | 8.158M -23.73% | 8.636M 13.29% | 10.559M 21.23% | 6.803M -2.33% | 8.109M -0.60% | 8.956M 3.71% | 10.547M -0.11% |
| EBIT Q2Q % growth | 1.766M -54.14% | 2.81M 21.70% | 2.47M 80.95% | 3.607M 97.86% | 3.906M 121.18% | 6.031M 114.63% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.01 -110.00% | 0.05 | -0.06 | -118.38% |
| Q1 2025 Q2Q % growth | 0.06 -68.42% | 0.06 | 0.00 | 5.59% |
| Q4 2024 Q2Q % growth | 0.04 -86.21% | 0.12 | -0.08 | -66.11% |
| Q3 2024 Q2Q % growth | 0.12 -69.23% | 0.10 | 0.02 | 22.23% |
| Q2 2024 Q2Q % growth | 0.10 -85.51% | 0.14 | -0.04 | -26.01% |
| Q1 2024 Q2Q % growth | 0.19 -77.38% | 0.17 | 0.02 | 8.77% |
| Q4 2023 Q2Q % growth | 0.29 -73.39% | 0.28 | 0.01 | 4.02% |
| Q3 2023 Q2Q % growth | 0.39 -63.55% | 0.42 | -0.03 | -6.09% |
| Q2 2023 Q2Q % growth | 0.69 -50.71% | 0.62 | 0.07 | 11.06% |
| Q1 2023 Q2Q % growth | 0.84 -50.59% | 0.76 | 0.08 | 10.21% |
| Q4 2022 Q2Q % growth | 1.09 -22.14% | 0.91 | 0.18 | 19.49% |
| Q3 2022 Q2Q % growth | 1.07 75.41% | 0.97 | 0.10 | 10.36% |
| Q2 2022 Q2Q % growth | 1.40 197.87% | 1.38 | 0.02 | 1.78% |
| Q1 2022 Q2Q % growth | 1.70 193.10% | 1.34 | 0.36 | 26.81% |
| Q4 2021 Q2Q % growth | 1.40 636.84% | 1.27 | 0.13 | 10.40% |
| Q3 2021 Q2Q % growth | 0.61 408.33% | 0.35 | 0.26 | 73.53% |
| Q2 2021 Q2Q % growth | 0.47 193.75% | 0.40 | 0.07 | 16.36% |
| Q1 2021 Q2Q % growth | 0.58 5,900.00% | 0.35 | 0.23 | 66.57% |
| Q4 2020 Q2Q % growth | 0.19 171.43% | 0.09 | 0.10 | 117.23% |
| Q3 2020 Q2Q % growth | 0.12 140.00% | -0.03 | 0.15 | 500.43% |
| Q2 2020 Q2Q % growth | 0.16 1,500.00% | -0.03 | 0.19 | 581.62% |
| Q1 2020 Q2Q % growth | -0.01 -150.00% | -0.02 | 0.01 | 40.83% |
| Q4 2019 Q2Q % growth | 0.07 | 0.06 | 0.01 | 18.61% |
| Q3 2019 Q2Q % growth | 0.05 | 0.01 | 0.04 | 289.97% |
| Q2 2019 Q2Q % growth | 0.01 | 0.00 | 0.01 | 328.53% |
| Q1 2019 Q2Q % growth | 0.02 | -0.04 | 0.06 | 152.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 274.072M -19.34% | 296.18M | -22.108M | -7.46% |
| Q1 2025 Q2Q % growth | 293.408M -22.62% | 311.59M | -18.182M | -5.84% |
| Q4 2024 Q2Q % growth | 309.94M -25.14% | 312.22M | -2.28M | -0.73% |
| Q3 2024 Q2Q % growth | 315.119M -28.75% | 316.42M | -1.301M | -0.41% |
| Q2 2024 Q2Q % growth | 339.771M -37.16% | 341.45M | -1.679M | -0.49% |
| Q1 2024 Q2Q % growth | 379.174M -39.11% | 381.57M | -2.396M | -0.63% |
| Q4 2023 Q2Q % growth | 414.035M -34.09% | 412.51M | 1.525M | 0.37% |
| Q3 2023 Q2Q % growth | 442.291M -30.47% | 452.78M | -10.489M | -2.32% |
| Q2 2023 Q2Q % growth | 540.695M -28.25% | 542.31M | -1.615M | -0.30% |
| Q1 2023 Q2Q % growth | 622.707M -21.05% | 606.9M | 15.807M | 2.60% |
| Q4 2022 Q2Q % growth | 628.2M -1.95% | 606.46M | 21.74M | 3.58% |
| Q3 2022 Q2Q % growth | 636.1M 69.67% | 629.89M | 6.21M | 0.99% |
| Q2 2022 Q2Q % growth | 753.6M 127.12% | 755.75M | -2.15M | -0.28% |
| Q1 2022 Q2Q % growth | 788.7M 139.58% | 760.55M | 28.15M | 3.70% |
| Q4 2021 Q2Q % growth | 640.7M 197.17% | 627.56M | 13.14M | 2.09% |
| Q3 2021 Q2Q % growth | 374.9M 93.25% | 326.88M | 48.02M | 14.69% |
| Q2 2021 Q2Q % growth | 331.8M 53.04% | 303.29M | 28.51M | 9.40% |
| Q1 2021 Q2Q % growth | 329.2M 56.69% | 294.98M | 34.22M | 11.60% |
| Q4 2020 Q2Q % growth | 215.6M 0.23% | 200.35M | 15.25M | 7.61% |
| Q3 2020 Q2Q % growth | 194M -7.27% | 178.06M | 15.94M | 8.95% |
| Q2 2020 Q2Q % growth | 216.8M 6.90% | 202.87M | 13.93M | 6.87% |
| Q1 2020 Q2Q % growth | 210.1M 7.63% | 214.22M | -4.12M | -1.92% |
| Q4 2019 Q2Q % growth | 215.1M | 212.39M | 2.71M | 1.28% |
| Q3 2019 Q2Q % growth | 209.2M | 206.71M | 2.49M | 1.20% |
| Q2 2019 Q2Q % growth | 202.8M | 203.39M | -590K | -0.29% |
| Q1 2019 Q2Q % growth | 195.2M | 203.15M | -7.95M | -3.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -54.16% | 0% | -55.32% |
| Revenue | 0% | -8.37% | 0% | -6.02% |